Entry Detail



General Information

Database ID:exR0089770
RNA Name:hsa-miR-33b-5p
RNA Type:miRNA
Chromosome:chr17
Starnd:-
Coordinate:
Start Site(bp):17813897End Site(bp):17813916
External Links:hsa-miR-33b-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ADCY9
chr16
3953387
4116442
-
AFF4
chr5
132875395
132963634
-
BTBD7
chr14
93237550
93333092
-
CERK
chr22
46684410
46738252
-
CROT
chr7
87345681
87399795
+
DDX5
chr17
64498254
64508199
-
E2F3
chr6
20401879
20493714
+
ECHDC1
chr6
127288712
127343609
-
EIF5A2
chr3
170888418
170908644
-
IGF1R
chr15
98648539
98964530
+
IRS2
chr13
109752695
109786583
-
MAPK1IP1L
chr14
55051647
55070194
+
MAPK6
chr15
51952106
52067375
+
MTHFD2
chr2
74198610
74217565
+
MYO19
chr17
36495633
36543435
-
NAA15
chr4
139301505
139420033
+
NFAT5
chr16
69565094
69704666
+
PIM1
chr6
37170152
37175428
+
RBM33
chr7
155644451
155781485
+
RCAN1
chr21
34513142
34615113
-
ROBO1
chr3
78597239
79767998
-
SLC39A8
chr4
102251041
102431258
-
SULF2
chr20
47656348
47786616
-
TNPO1
chr5
72816312
72916733
+
TPM1
chr15
63042632
63071915
+
UBN2
chr7
139230356
139308236
+
WDFY3
chr4
84669610
84966391
-
XRN1
chr3
142306607
142448062
-
ZFYVE16
chr5
80408013
80483379
+
ZNF148
chr3
125225561
125375354
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0000540
chr14
55799534
55821940
+
hsa_circ_0001349
chr3
152132729
152150709
+
hsa_circ_0000642
chr15
80390757
80415142
+
hsa_circ_0000643
chr15
80412669
80415142
+
hsa_circ_0000284
chr11
33307958
33309057
+
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC023509.1
chr12
53441741
53467528
+
DANCR
chr4
52712404
52720351
+
FGD5-AS1
chr3
14920347
14948424
-
MCF2L-AS1
chr13
112967484
112968824
-
NEAT1
chr11
65422774
65445540
+
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.